Pneumonia

The antipseudomonal cephalosporin/β-lactamase inhibitor combination ceftolozane/tazobactam could be a potential treatment option for cystic fibrosis (CF) pulmonary exacerbations. The pharmacokinetics (PK) of...

The pandemic of a novel coronavirus, termed SARS-CoV-2, has created an unprecedented global health burden. To investigate the effect of the SARS-CoV-2 infection on maternal, fetal, and neonatal morbidity and other poor...

Since making its debut on the global stage in December 2019, Coronavirus Disease 2019 (COVID-19) has afflicted nearly four million people and caused hundreds of thousands of deaths. Case reports and case series depicting the...

In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the end of April, 2020, over 3 million people had been...

In December, 2019, the newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China, causing COVID-19, a respiratory disease presenting with fever, cough, and often pneumonia. WHO has set...

To investigate the CT findings of patients with different clinical types of coronavirus disease 2019 (COVID-19).A total of 67 patients diagnosed as COVID-19 by nucleic acid testing were collected and divided into 4 groups...

Background Atypical manifestations of COVID-19 are being encountered as the pandemic unfolds, leading to non-chest CT scans that may uncover unsuspected pulmonary disease. Purpose To investigate patients with primary...

Electronic cigarettes have rapidly attracted interest as a method to help people quit smoking, on the premise that e-cigarettes are less harmful than tobacco. However, so far studies have not provided convincing evidence that...

Bacterial infectious diseases are a major threat to human health. Timely and sensitive pathogenic bacteria detection is crucial in bacterial contaminations identification and preventing the spread of infectious diseases. Due to...